FDA Issues Report With Caution On Long-Term Usage of Bisphosphonates

In mid-May, the FDA finally took a position on the controversial bisphosphonates prescribed as treatment for osteoporosis in postmenopausal women. (1) Of late the bisphosphonates class of drugs had been gathering an increasing amount of evidence of dire side effects Read on! →

Oral Bisphosphonates Also Spell Trouble For The Eye: Finding

Oral bisphosphonates have some more flak to fend off with findings of a new study coming in from Canada pointing that usage of the drug class puts the osteoporosis patients at an increased risk of developing serious inflammatory eye diseases Read on! →

Generic Boniva Now Available For The U.S Markets

Biphosphonate class drug Boniva also sold worldwide under the brand names Bonviva and Bondronat is now available for sale in the United States. The Food and Drug Administration has approved it’s use – prescription by doctors and distribution in pharmacies Read on! →